Switch from an oral dopamine agonist to rotigotine transdermal patch in Parkinson's disease

被引：0
|
作者：
LeWitt, P. A.
Patton, J. M.
MacMahon, D. G.
Jankovic, J.
机构：
来源：
MOVEMENT DISORDERS | 2007年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
338
引用
收藏
页码：S104 / S104
页数：1
相关论文
共 50 条
  • [31] Rotigotine transdermal patch in the treatment of Parkinson's disease and restless legs syndrome
    Kenney, Christopher
    Jankovic, Joseph
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (09) : 1329 - 1335
  • [32] Rotigotine transdermal patch and sleep in Parkinson’s disease: where are we now?
    Miguel Rosa-Grilo
    Mubasher A. Qamar
    Raquel N. Taddei
    Javier Pagonabarraga
    Jaime Kulisevsky
    Anna Sauerbier
    K. Ray Chaudhuri
    npj Parkinson's Disease, 3
  • [33] Treatment of nocturnal symptoms of Parkinson's disease using rotigotine Transdermal patch
    Chaudhuri, R.
    Jankovic, J.
    Trenkwalder, C.
    Boroojerdi, B.
    MOVEMENT DISORDERS, 2007, 22 (12) : VI - VI
  • [34] Improvement of Swallowing Functions By Rotigotine Transdermal Patch in Patients with Parkinson's Disease
    Isono, Chiharu
    Hirano, Makito
    Sakamoto, Hikaru
    Ueno, Shuichi
    Kusunoki, Susumu
    Nakamura, Yusaku
    ANNALS OF NEUROLOGY, 2015, 78 : S51 - S51
  • [35] Rotigotine Transdermal Patch A Review of its Use in the Treatment of Parkinson's Disease
    Sanford, Mark
    Scott, Lesley J.
    CNS DRUGS, 2011, 25 (08) : 699 - 719
  • [36] ROTIGOTINE TRANSDERMAL PATCH FOR THE TREATMENT OF PARKINSON'S DISEASE AND RESTLESS LEGS SYNDROME
    Boroojerdi, B.
    Wolff, H. -M.
    Braun, M.
    Scheller, D. K. A.
    DRUGS OF TODAY, 2010, 46 (07) : 483 - 505
  • [37] Reduction of gastrointestinal symptoms in Parkinson's disease after a switch from oral therapy to rotigotine transdermal patch: A non-interventional prospective multicenter trial
    Woitalla, Dirk
    Kassubek, Jan
    Timmermann, Lars
    Lauterbach, Thomas
    Berkels, Reinhard
    Grieger, Frank
    Mueller, Thomas
    PARKINSONISM & RELATED DISORDERS, 2015, 21 (03) : 199 - 204
  • [38] Caregivers' and physicians' attitudes to rotigotine transdermal patch versus oral Parkinson's disease medication: an observational study
    Sieb, Joern Peter
    Themann, Peter
    Warnecke, Tobias
    Lauterbach, Thomas
    Berke, Reinhard
    Grieger, Frank
    Lorenzl, Stefan
    CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (05) : 967 - 974
  • [39] Dopamine dysregulation syndrome is similarly common among Parkinson's disease patients treated with rotigotine transdermal patch as with ropinirole
    Giladi, N.
    Shabtai, H.
    Levi, A.
    Gurevich, T.
    Balash, Y.
    Girshovich, I.
    Peretz, C.
    MOVEMENT DISORDERS, 2007, 22 : S241 - S241
  • [40] Switch from oral pramipexole or ropinirole to rotigotine transdermal system in advanced Parkinson's disease: an open-label study
    Chung, Sun Ju
    Kim, Jong-Min
    Kim, Jae Woo
    Jeon, Beom Seok
    Singh, Pritibha
    Thierfelder, Stephan
    Ikeda, Junji
    Bauer, Lars
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (07) : 961 - 970
12345